Kaufman JL - Search Results

1

Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma.

Lonial S, Jacobus S, Fonseca R, Weiss M, Kumar S, Orlowski RZ, Kaufman JL, Yacoub AM, Buadi FK, O'Brien T, Matous JV, Anderson DM, Emmons RV, Mahindra A, Wagner LI, Dhodapkar MV, Rajkumar SV. Lonial S, et al. Among authors: kaufman jl. J Clin Oncol. 2020 Apr 10;38(11):1126-1137. doi: 10.1200/JCO.19.01740. Epub 2019 Oct 25. J Clin Oncol. 2020. PMID: 31652094 Free PMC article. Clinical Trial.

2

Novel treatment approaches for patients with multiple myeloma.

Sinha R, Kaufman JL, Lonial S. Sinha R, et al. Among authors: kaufman jl. Clin Lymphoma Myeloma. 2006 Jan;6(4):281-8. doi: 10.3816/CLM.2006.n.002. Clin Lymphoma Myeloma. 2006. PMID: 16507205 Review.

3

Proteasome inhibition: novel therapy for multiple myeloma.

Kaufman JL, Lonial S. Kaufman JL, et al. Onkologie. 2006 Apr;29(4):162-8. doi: 10.1159/000091692. Epub 2006 Mar 29. Onkologie. 2006. PMID: 16601373 Review.

4

Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study.

Chanan-Khan AA, Kaufman JL, Mehta J, Richardson PG, Miller KC, Lonial S, Munshi NC, Schlossman R, Tariman J, Singhal S. Chanan-Khan AA, et al. Among authors: kaufman jl. Blood. 2007 Mar 15;109(6):2604-6. doi: 10.1182/blood-2006-09-046409. Epub 2006 Nov 30. Blood. 2007. PMID: 17138816 Free article.

5

Multiple myeloma presenting with advanced renal failure: a case report and new treatment options.

Gladney SP, Lonial S, Kaufman JL. Gladney SP, et al. Among authors: kaufman jl. Clin Lymphoma Myeloma. 2008 Feb;8(1):52-4. doi: 10.3816/CLM.2008.n.004. Clin Lymphoma Myeloma. 2008. PMID: 18501088

6

Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up-regulation of death receptors.

David E, Sinha R, Chen J, Sun SY, Kaufman JL, Lonial S. David E, et al. Among authors: kaufman jl. Clin Cancer Res. 2008 Aug 15;14(16):5090-8. doi: 10.1158/1078-0432.CCR-08-0016. Clin Cancer Res. 2008. PMID: 18698026

7

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

Richardson PG, Weller E, Lonial S, Jakubowiak AJ, Jagannath S, Raje NS, Avigan DE, Xie W, Ghobrial IM, Schlossman RL, Mazumder A, Munshi NC, Vesole DH, Joyce R, Kaufman JL, Doss D, Warren DL, Lunde LE, Kaster S, Delaney C, Hideshima T, Mitsiades CS, Knight R, Esseltine DL, Anderson KC. Richardson PG, et al. Among authors: kaufman jl. Blood. 2010 Aug 5;116(5):679-86. doi: 10.1182/blood-2010-02-268862. Epub 2010 Apr 12. Blood. 2010. PMID: 20385792 Free PMC article. Clinical Trial.

8

Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma: a retrospective study.

Kaufman JL, Nooka A, Vrana M, Gleason C, Heffner LT, Lonial S. Kaufman JL, et al. Cancer. 2010 Jul 1;116(13):3143-51. doi: 10.1002/cncr.25143. Cancer. 2010. PMID: 20564642 Free article.

9

Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes.

David E, Kaufman JL, Flowers CR, Schafer-Hales K, Torre C, Chen J, Marcus AI, Sun SY, Boise LH, Lonial S. David E, et al. Among authors: kaufman jl. Blood. 2010 Dec 9;116(24):5285-8. doi: 10.1182/blood-2010-03-272393. Epub 2010 Sep 15. Blood. 2010. PMID: 20844234 Free PMC article.

10

Putting the E (evidence) in a new Era for myeloma.

Kaufman JL, Lonial S. Kaufman JL, et al. Leuk Lymphoma. 2011 Mar;52(3):349-50. doi: 10.3109/10428194.2011.557170. Leuk Lymphoma. 2011. PMID: 21323515 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page